Skip to content

LegitScript Pharmacy Certification Includes Probationary Status to Help Previously Noncompliant Applicants

LegitScript announces new probationary status category.

Probationary Certification Category Explained

In a 2017 blog post, John Horton, CEO, and President of LegitScript, explained the introduction of the Probationary Status category in LegitScript's pharmacy merchant certification.

NOTE: Probationary certification has been an active offering since 2017.

Why a Probationary Category Is Necessary

LegitScript pharmacy certification is intended to distinguish between pharmacy or telemedicine merchants that are operating lawfully and those that are not. Sometimes, however, an applicant has had some fairly serious problems in the past, but indicates they have fixed the issues and intend to operate in compliance going forward.

In these cases, I’m often hesitant to put LegitScript’s name and brand behind the applicant as being “LegitScript-approved.” But I’m also hesitant not to approve them, as long as they remain licensed and are now fully legally compliant. After all, we want to incentivize and reward discontinuation of problematic activity.

So the challenges have been: how can we offer certification to these sorts of applicants, while recognizing that enhanced scrutiny is needed; and how can we convey to the public that even though we are certifying the applicant, we’re cognizant of prior problems and watching closely for them?

About Probationary Status

In response, we’re creating the Probationary Status category for healthcare merchants that we’ve identified as having engaged in past illicit activity. Here are some of the parameters for eligibility:

  • There is compelling evidence of problematic activity that is both serious and fairly recent (e.g., within the last five years). Note that prior discipline alone doesn’t mean that a pharmacy’s only option is probationary — rather, it has to be pretty serious stuff, such as importing unapproved drugs or selling prescription drugs without a prescription.
  • We have to be convinced that the behavior has stopped, and that it won’t re-occur.
  • As part of this, we’ll require full disclosure regarding the circumstances of the violation. We expect the applicant to take responsibility for it (not simply offer excuses!) and to present a remediation plan.

Applicants certified with probationary status will be subject to a higher level of scrutiny and monitoring going forward. As part of the certification process, we’ll likely be asking for additional documentation and information. Our website will identify the applicant as certified and thus legitimate, but we will also note that the merchant is on probationary status and explain why.

It’s important to emphasize that Probationary Status is not for pharmacies that are operating legally in one jurisdiction but illegally elsewhere.

Probationary status isn’t a “wink-wink” at illegal behavior. It’s full certification, and as such requires full compliance with our standards.

A few other points. In general, our goal is for probationary status to last no longer than three years. (It is a minimum of one year.) It’s also a one-shot deal: if an applicant is certified with probationary status, and we find out that the problematic behavior has resumed, was never truly discontinued, or that the application did not disclose material facts about the activity, the applicant will receive a lifetime bar from LegitScript approval, and will be classified as rogue or unapproved going forward. As to pricing, it will be on a case-by-case basis, but will typically cost more than standard certification, simply because our monitoring is going to be more intensive.

All of that said, I think this is the right approach to take: if a pharmacy or telemedicine merchant has fixed past problems that were serious, and is now in compliance everywhere it is operating, and its licensing authority (e.g., board of pharmacy) has seen fit to allow it to maintain its professional license as a pharmacy or other healthcare provider, we want to recognize that. But it’s also incumbent upon us to convey to our partners, and to internet users, that we are aware of prior problems and are watching carefully to ensure that they do not re-occur.

For any further questions, contact us.

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

Merchant Onboarding Essentials: What You Need to Know

Modern merchant onboarding involves much more than collecting documents - it's about building a smart, scalable risk management process that can keep up with changing technology and fraud tactics. Whether you're launching a payments platform or refining your underwriting approach, getting onboarding...

LegitScript Marketplace Risk Panel Recap: The Dark Side of Weight-Loss Drugs: Regulation, Risk, and Red Flags

Marketplaces and other online platforms must constantly revisit and stress test their policies to ensure they are properly mitigating risk while providing sufficient room for growth. But what happens when a new regulation or trend upends those policies? Listen below to an excerpt of the panel discus...

Trust, Risk, and the Future of Compliance: Key Takeaways from Marketplace Risk San Francisco 2025

Marketplace Risk San Francisco 2025 offered a rare opportunity to pause the noise and listen closely to the industry, to its undercurrents, and to the questions no one's asking on stage. Once you're tuned in, you begin to hear the real story: an acute urgency around platform trust, growing anxieties...

Partnering for Compliance: What Platforms and Pharmaceutical Manufacturers Need to Know

Pharmaceutical manufacturing is a quickly growing sector that in recent years has been riding a wave of demand resulting from the booming telehealth industry, GLP-1 weight loss drugs, and an aging population requiring increasing medical care. Keep reading to understand how pharmaceutical manufacturi...